home All News open_in_new Full Article

Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI

– First Level 1 study comparing an emerging technology head-to-head with RP in men with prostate cancer – – TULSA had no blood loss and no overnight stay, along with reduced post-procedure pain, and more rapid recovery to baseline activities and overall health – TORONTO, April 29, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; […]


today 7 h. ago attach_file Other

attach_file Other
attach_file Sport
attach_file Economics
attach_file Economics
attach_file Other
attach_file Science
attach_file Other
attach_file Events
attach_file Sport
attach_file Other
attach_file Politics
attach_file Other
attach_file Other
attach_file Other
attach_file Politics
attach_file Events
attach_file Economics
attach_file Sport
attach_file Events
attach_file Other


ID: 502940193
Add Watch Country

arrow_drop_down